Singapore is the underwriting seat for Southeast Asian healthcare.
One legal and capital hub, six materially different health systems. We use Singapore to structure regional platforms that can operate in Indonesia, Vietnam, Malaysia, Thailand and the Philippines without re-founding themselves each time.
What we fund in the region
Multi-country care delivery and specialty networks with real clinical governance and unit economics that survive without subsidy.
Diagnostics and lab consolidation plays where scale reduces cost per test and improves access simultaneously.
Biotech and MedTech using Singapore IP structures with manufacturing in India or Vietnam.
Structuring discipline
We prefer Singapore holdcos with clean cap tables, transparent related-party history and audited regional subsidiaries.
Regulatory and payer variance across ASEAN is a diligence subject, not a footnote; we model each market separately before committing.
Frequently asked questions
- Which countries does the Singapore desk cover?
- Singapore, Indonesia, Vietnam, Malaysia, Thailand and the Philippines, with selective coverage of Cambodia and Myanmar.
- Do you invest in Singapore-incorporated holdcos with foreign operations?
- Yes, and that is our preferred structure for regional healthcare platforms.
- What is your minimum cheque in Southeast Asia?
- US$10 million at Series A or B, with follow-on reserves.